| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 1.12 MB | Adobe PDF |
Advisor(s)
Abstract(s)
Fungal species have demonstrated great potential to produce a wide range of metabolites, including enzymes, antibiotics, and other bioactive compounds with therapeutic interest. Prostate cancer (PCa) is one of the most frequent cancers in men. This type of tumors have high levels of heterogeneity, leading to therapeutic failures and increasing resistance against chemotherapeutic drugs. Hence, is essential to research new therapeutic agents against PCa. Exploring the rich reservoir of fungal diversity, this study aims to uncover bioactive compounds that may serve as valuable candidates for developing novel therapeutics against prostate cancer. Isolation from chestnuts, chestnut flour and sunflower seeds led to the creation of a fungal collection of 165 isolates. Fungi isolates grew in flask cultures for 15 days, and culture broths were extracted with ethyl acetate. Human prostate epithelial cells (HPepiC) and the human prostate cancer cell line (PC3) were exposed to the fungal extracts at a concentration 100 μg/mL, and cell viability was evaluated by MTT assay. Results show that several fungal extracts significantly reduce the viability of tumor cells, with some showing little to no effect on healthy human cells, however, species identification is essential to carry on our studies.
Description
Keywords
Prostate cancer HPepiC
Citation
Ferreira, D., Rocha, A. C., Baylina, P., Sieiro, C., & Fernandes, R. (2023). Potential anticancer activity from food-isolated fungi extracts. Em R. P. Rocha & J. L. Faria (Eds.), Livro de Resumos do XXVII Encontro Luso-Galego de Química (p. 43). Sociedade Portuguesa de Química.
Publisher
Sociedade Portuguesa de Química